ArCom® and ArComXL® Polyethylene Data Collection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-07-31

Study Completion Date

2020-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this prospective clinical data-collection is to document the performance, clinical outcomes, and wear rates of ArCom® and ArComXL® Polyethylene. The data gathered will be collated and used as a part of Biomet's post-market surveillance system and to provide feedback to designing engineers, support marketing efforts, and answer potential questions from reimbursement agencies.

Inclusion/exclusion criteria are identical to those indications and contraindications stated in the FDA approved labeling for the device in 510(k) K926107 and 510(k) K043051. Surgical techniques and patient care are to be standard for the surgeons participating in the protocol.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement

NCT00698152

Osteoarthritis Avascular Necrosis Rheumatoid Arthritis

COMPLETED

A Comparison of the Persona Total Knee Arthroplasty System Using CR or MC Polyethylene

NCT03568123

Knee Osteoarthritis

COMPLETED NA

Zimmer Trabecular Metal Total Ankle PMCF

NCT02038140

Degenerative Arthritis Rheumatoid Arthritis Post Traumatic Arthritis

ACTIVE_NOT_RECRUITING NA

Vitamin E-Diffused Highly Cross-Linked Polyethylene Liner

NCT02801019

Osteoarthritis

COMPLETED NA

Study of an All Polyethylene Tibial Component

NCT02540902

Knee Replacement

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study follow-up intervals are 6 weeks, 1 year, 2 years, 3 years, 5 years, and 10 years. Demographic data is collected pre-operatively along with the Harris Hip Score and UCLA Activity Score. Operative information includes the surgical technique and other standard operative information. Follow-up information includes the Harris Hip Score, UCLA Activity Score, and Radiographic data. Anterior/posterior and frog leg lateral X-ray data is recorded to show radiolucencies, component position and angles. Sites are also required to send in an Anterior/Posterior Pelvis x-ray for wear analysis. Implant durability is documented by asking the surgeon to record revisions, complications, and device related adverse events. All information collected is de-identified in compliance with HIPAA regulations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis of Hip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ArCom® Polyethylene

Intervention Type DEVICE

Argon packaged compression molded polyethylene

ArComXL® Polyethylene

Intervention Type DEVICE

Highly crosslinked Ultra High Molecular Weight Polyethylene

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ArCom® Polyethylene

Argon packaged compression molded polyethylene

Intervention Type DEVICE

ArComXL® Polyethylene

Highly crosslinked Ultra High Molecular Weight Polyethylene

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
* Rheumatoid arthritis
* Correction of functional deformity
* Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
* Revision of previously failed total hip arthroplasty